Details for 2021212400

Up to date per 04.04.2026

Actions

Title / Product Name

SIPONIMOD MIT DOSIERUNGSSCHEMA MIT SOFORTIGER FREISETZUNG ZUR BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021212400

EP Publication Number

4074312

E-Number

1890080

Language

PCT Number

Publication Date

19.10.2022 A

25.02.2026 B1

Registration Date

25.02.2026

AT Publication Date

15.03.2026

Application Date

08.04.2015

Registration Number

Priorities

10.04.2014

201461977816 P

IPC

A61K 31/397 20060101AFI20220905BHEP

Maximum Duration of Protection

08.04.2035

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

Bouillot, Philippe Michel Rene 4002 BaselCH

Dahlke, Frank 4002 BaselCH

Legangneux, Eric 4002 BaselCH

Reynaud, Emeric 4002 BaselCH

Wallström, Erik 4002 BaselCH

Information about Fees